Literature DB >> 10820008

Deimination of myelin basic protein. 1. Effect of deimination of arginyl residues of myelin basic protein on its structure and susceptibility to digestion by cathepsin D.

L B Pritzker1, S Joshi, J J Gowan, G Harauz, M A Moscarello.   

Abstract

The effect of deimination of arginyl residues in bovine myelin basic protein (MBP) on its susceptibility to digestion by cathepsin D has been studied. Using bovine component 1 (C-1) of MBP, the most unmodified of the components with all 18 arginyl residues intact, we have generated a number of citrullinated forms by treatment of the protein with purified peptidylarginine deiminase (PAD) in vitro. We obtained species containing 0-9.9 mol of citrulline/mol of MBP. These various species were digested with cathepsin D, a metalloproteinase which cleaves proteins at Phe-Phe linkages. The rate of digestion compared to component 1 was only slightly affected when 2.7 or 3.8 mol of citrulline/mol of MBP was present. With 7.0 mol of citrulline/mol of MBP, a large increase in the rate of digestion occurred. No further increase was observed with 9.9 mol of citrulline/mol of MBP. The immunodominant peptide 43-88 (bovine sequence) was released slowly when 2.7 and 3.8 mol of citrulline/mol of MBP was present, but it was released rapidly when 7.0 mol of citrulline/mol of MBP was present. The dramatic change in digestion with 7.0 mol of citrulline/mol of MBP or more could be explained by a change in three-dimensional structure. Molecular dynamics simulation showed that increasing the number of citrullinyl residues above 7 mol/mol of MBP generated a more open structure, consistent with experimental observations in the literature. We conclude that PAD, which deiminates arginyl residues in proteins, decreases both the charge and compact structure of MBP. This structural change allows better access of the Phe-Phe linkages to cathepsin D. This scheme represents an effective way of generating the immunodominant peptide which sensitizes T-cells for the autoimmune response in demyelinating disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10820008     DOI: 10.1021/bi9925569

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  61 in total

1.  Site-specific degradation of myelin basic protein by the proteasome.

Authors:  A A Belogurov; N A Ponomarenko; V M Govorun; A G Gabibov; A V Bacheva
Journal:  Dokl Biochem Biophys       Date:  2009 Mar-Apr       Impact factor: 0.788

Review 2.  Epigenetics of multiple sclerosis: an updated review.

Authors:  Cem İsmail Küçükali; Murat Kürtüncü; Arzu Çoban; Merve Çebi; Erdem Tüzün
Journal:  Neuromolecular Med       Date:  2014-03-21       Impact factor: 3.843

Review 3.  Oxidative Modifications in Tissue Pathology and Autoimmune Disease.

Authors:  Mei-Ling Yang; Hester A Doyle; Steven G Clarke; Kevan C Herold; Mark J Mamula
Journal:  Antioxid Redox Signal       Date:  2017-12-11       Impact factor: 8.401

4.  Post-translational modifications in the rat lumbar spinal cord in experimental autoimmune encephalomyelitis.

Authors:  Jennifer E Grant; Jun Hu; Tong Liu; Mohit R Jain; Stella Elkabes; Hong Li
Journal:  J Proteome Res       Date:  2007-06-13       Impact factor: 4.466

5.  Interactions of the 18.5 kDa isoform of myelin basic protein with Ca2+-calmodulin: in vitro studies using gel shift assays.

Authors:  David S Libich; George Harauz
Journal:  Mol Cell Biochem       Date:  2002-12       Impact factor: 3.396

6.  Adduction of cholesterol 5,6-secosterol aldehyde to membrane-bound myelin basic protein exposes an immunodominant epitope.

Authors:  Natalie K Cygan; Johanna C Scheinost; Terry D Butters; Paul Wentworth
Journal:  Biochemistry       Date:  2011-02-28       Impact factor: 3.162

7.  The development of N-α-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-α-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine amide (o-Cl-amidine) as second generation protein arginine deiminase (PAD) inhibitors.

Authors:  Corey P Causey; Justin E Jones; Jessica L Slack; Daisuke Kamei; Larry E Jones; Venkataraman Subramanian; Bryan Knuckley; Pedram Ebrahimi; Alexander A Chumanevich; Yuan Luo; Hiroshi Hashimoto; Mamoru Sato; Lorne J Hofseth; Paul R Thompson
Journal:  J Med Chem       Date:  2011-09-16       Impact factor: 7.446

8.  Lupus autoimmunity altered by cellular methylation metabolism.

Authors:  Mei-Ling Yang; Alaric J P Gee; Renelle J Gee; Cecilia I Zurita-Lopez; Shilpi Khare; Steven G Clarke; Mark J Mamula
Journal:  Autoimmunity       Date:  2012-11-01       Impact factor: 2.815

9.  Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity.

Authors:  A J Slavin; J M Soos; O Stuve; J C Patarroyo; H L Weiner; A Fontana; E K Bikoff; S S Zamvil
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

10.  Deimination of membrane-bound myelin basic protein in multiple sclerosis exposes an immunodominant epitope.

Authors:  Abdiwahab A Musse; Joan M Boggs; George Harauz
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.